Design Therapeutics (DSGN) Common Equity (2020 - 2026)
Design Therapeutics (DSGN) posted Common Equity of $201.86 million for Q2 2026, down 5.2% from $213.04 million a year earlier and down 7.4% from the prior quarter.
Design Therapeutics (DSGN) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Design Therapeutics' Common Equity came in at $212.5 million, down 12.2% from FY2024.
- Annual Common Equity has declined for four consecutive years.
- In prior years, Design Therapeutics' Common Equity was $242.1 million in FY2024 (-12.8%), $277.69 million in FY2023 (-15.2%), $327.31 million in FY2022 (-14.3%) and $382.13 million in FY2021.
- Quarterly Common Equity has run from a low of $199.72 million in Q3 2025 to a high of $391.56 million in Q3 2021 over five years.
- On a year-over-year basis, Common Equity has declined in each of the last 18 quarters, with an average decline of 12.6% over the last eight quarters.
- The year-over-year decline in Common Equity has ranged between 4.3% (Q1 2026) and 20.9% (Q3 2025) over the last five years.
- According to Business Quant data, Common Equity for the three prior quarters was $218.05 million (Q1 2026), $212.5 million (Q4 2025) and $199.72 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,140.41 Bn | 1,108.99 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 618.57 Bn | 537.10 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 509.95 Bn | 483.06 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 366.63 Bn | 321.01 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.47 Bn | 262.46 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 263.21 Bn | 236.89 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 236.71 Bn | 192.11 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 193.05 Bn | 167.25 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 171.45 Bn | 118.10 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Design Therapeutics | 696.93 Mn | -159.10 Mn | - | 201.86 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 201.86 Mn |
| Mar 31, 2026 | 218.05 Mn |
| Dec 31, 2025 | 212.50 Mn |
| Sep 30, 2025 | 199.72 Mn |
| Jun 30, 2025 | 213.04 Mn |
| Mar 31, 2025 | 227.92 Mn |
| Dec 31, 2024 | 242.10 Mn |
| Sep 30, 2024 | 252.45 Mn |
| Jun 30, 2024 | 261.24 Mn |
| Mar 31, 2024 | 269.56 Mn |
| Dec 31, 2023 | 277.69 Mn |
| Sep 30, 2023 | 284.96 Mn |
| Jun 30, 2023 | 296.80 Mn |
| Mar 31, 2023 | 312.82 Mn |
| Dec 31, 2022 | 327.31 Mn |
| Sep 30, 2022 | 340.94 Mn |
| Jun 30, 2022 | 357.16 Mn |
| Mar 31, 2022 | 370.31 Mn |
| Dec 31, 2021 | 382.13 Mn |
| Sep 30, 2021 | 391.56 Mn |
Design Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=DSGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "DSGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=DSGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();